Lentiviral Vectors Products
Our patented solutions offer 100% of target cells transduction, in vitro and in vivo
Vectalys for you
Stay updated with our latest events and breaking news
News & events
CRISPR congress in Berlin20-10-2016We look forward to sharing with you the results of our new non-integrative MS2-based lentiviral par … Read more
Fundraising : Vectalys raises 0,9M€29-06-2016We are pleased to announce our 0,9M€ fundraising.
Vectalys will attend the ASGCT in Washington29-04-2016Vectalys will attend the ASGCT on May 4-7, 2016 in Washington, DC to introduce the next generation … Read more